Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report

Guillaume Beziat,Martin Gauthier,Caroline Protin,Lucie Oberic,Fleur Lerebours,Jasmine Carlier,Loic Ysebaert

Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report

2020

Guillaume Beziat
Martin Gauthier
Caroline Protin
Lucie Oberic
Fleur Lerebours
Jasmine Carlier
Loic Ysebaert

Venetoclax with high-dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.

Keywords:

Methotrexate
Internal medicine
Venetoclax
Pathology
Central nervous system
Oncology
Rituximab
Medicine
Chronic lymphocytic leukemia
high dose methotrexate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations